Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Serum Vasohibin, Cardiotrophin, Endocan & Perinatal Outcomes

Investigation of First Trimester Serum Vasohibin-1, Vasohibin-2, Cardiotrophin-1 and Endocan Concentrations in Predicting Adverse Perinatal Outcomes

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Investigation of the relationship between maternal serum vasohibin-1, vasohibin-2, cardiotrophin -1 and endocan concentrations at the 11th and 14th weeks of gestation and adverse perinatal outcomes.

Who May Be Eligible (Plain English)

Who May Qualify: - Those who had the first-trimester screening test between 11 and 14 weeks of pregnancy and are in the low-risk group - Those with singleton pregnancy - Those who did not conceive pregnancy with assisted reproductive treatment methods - Those who do not have any pregestational diseases - Those who do not have any uterine anomalies Who Should NOT Join This Trial: - Smokers - Those who are in the high-risk group with the first trimester screening test - Those with multiple pregnancies - Those who conceive with assisted reproductive treatment methods - Those who had any disease before pregnancy - Those who have any uterine anomalies Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Those who had the first-trimester screening test between 11 and 14 weeks of pregnancy and are in the low-risk group * Those with singleton pregnancy * Those who did not conceive pregnancy with assisted reproductive treatment methods * Those who do not have any pregestational diseases * Those who do not have any uterine anomalies Exclusion Criteria: * Smokers * Those who are in the high-risk group with the first trimester screening test * Those with multiple pregnancies * Those who conceive with assisted reproductive treatment methods * Those who had any disease before pregnancy * Those who have any uterine anomalies

Treatments Being Tested

DIAGNOSTIC_TEST

first trimester serum diagnostic test

First trimester serum vasohibin-1, vasohibin-2, cardiotropin-1 and endocan concentrations predict adverse perinatal outcomes

Locations (1)

Ümraniye Eğitim ve Araştırma Hastanesi
Istanbul, Ümraniye, Turkey (Türkiye)